Figure 1.

Schematic presentation of patient selection and entry criteria for randomization with ASSP. Monoclonal P. falciparum infections contained a single allelic form of infection i.e. either of mspI or mspII or glurp. Polyclonal infections along with Pf, Pv mixed infections were excluded. Only P. falciparum monoclonal infections were selected for the study. Patients with additional P. vivax co-infection during the follow-up scheduled were excluded. Patients, who had not completed the 42 days follow-up schedule, were eliminated.